home / stock / ctso / ctso news

CTSO News and Press, CytoSorbents Corporation

Stock Information
Company Name: CytoSorbents Corporation
Stock Symbol: CTSO
Market: NASDAQ
Website: cytosorbents.com
Menu
CTSO CTSO Quote CTSO Short CTSO News CTSO Articles CTSO Message Board
Get CTSO Alerts

News, Short Squeeze, Breakout and More Instantly...
CTSO - CytoSorbents to Present at the Inaugural American Association of Physicians of Indian Origin (AAPI) World Health Congress

PRINCETON, N.J., July 17, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, announces it will present...
CTSO - CytoSorbents gets new $20M credit facility

2024-07-02 07:06:13 ET More on Cytosorbents CytoSorbents reports regulatory approval of CytoSorb in Taiwan Seeking Alpha’s Quant Rating on Cytosorbents Read the full article on Seeking Alpha For further details see: CytoSorbents gets new $20M credi...

CTSO - CytoSorbents Secures $20 Million Credit Facility

PRINCETON, N.J., July 02, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, announced that on...

CTSO - CytoSorbents reports regulatory approval of CytoSorb in Taiwan

2024-06-24 07:43:04 ET More on Cytosorbents Cytosorbents Corporation (CTSO) Q1 2024 Earnings Call Transcript Seeking Alpha’s Quant Rating on Cytosorbents Historical earnings data for Cytosorbents Financial information for Cytosorbents Read th...
CTSO - CytoSorbents Announces Regulatory Approval of CytoSorb® in Taiwan

PRINCETON, N.J., June 24, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, announces the reg...

CTSO - CytoSorbents Announces the Launch and Immediate Availability of the PuriFi(TM) Blood Pump in the European Union

PRINCETON, N.J., June 13, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, announces the lau...

CTSO - CytoSorbents to Host its 2024 Virtual Annual Stockholders Meeting

PRINCETON, N.J., June 05, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announces that it will host its 2024 Virtual Annual Stockholders Me...
CTSO - CytoSorbents STAR Registry Data on Patients on Ticagrelor Undergoing CABG Surgery with CytoSorb Presented at EuroPCR 2024. Named Top Five Finalist for Best Scientific Abstract

PRINCETON, N.J., June 04, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, announces the recent ...

CTSO - Blood Purification Medical Devices Stocks in the News

2024-06-03 10:10:00 ET June 3, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform, releases the first of a two-part series looking at medical device advancements for blood purification, featuring Aethlon Medical, Inc. (Nasdaq: AEMD ), a medical ther...

CTSO - Cytosorbents Corporation (CTSO) Q1 2024 Earnings Call Transcript

2024-05-09 23:01:03 ET Cytosorbents Corporation (CTSO) Q1 2024 Earnings Conference Call May 9, 2024 16:30 ET Company Participants Eric Ribner - Investor Relations Phil Chan - Chief Executive Officer Vincent Capponi - President and Chief Operating Officer Kath...
Next 10